Jan, 2021 Pharma & Healthcare
Global Pediatric Drugs and Vaccines Market 2020 By Manufacturers, Regions, Type, Application And Forecast Till 2027
Category by- Pharma & Healthcare , No. of Pages - 150, Published By - Ameco Research
The global Pediatric Drugs and Vaccines market size is projected to reach US$ 176440 million by 2026, from US$ 104980 million in 2020, at a CAGR of 9.0% during 2021-2026.
The global Pediatric Drugs and Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Geographical Analysis:
Based on region, the global Pediatric Drugs and Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Pediatric Drugs and Vaccines market are
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application
Newborn
Infant
Child
The global Pediatric Drugs and Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Geographical Analysis:
Based on region, the global Pediatric Drugs and Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Pediatric Drugs and Vaccines market are
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application
Newborn
Infant
Child